Christopher Kong, Glasgow Royal Infirmary
British Society of Gastroenterology Annual Meeting. Birmingham, March 20-23, 2006
A combination of a drug and an photophoresis machine has been used in an attempt to inactivate white cells among patients with Crohn’s disease. The experimental treatment uses the combined action of methoxypsoralen and ultra-violet light to produce a biological effect which could benefit patients whose Crohn’s disease is refractory to other forms of treatment. At the British Society of Gastroenterology Annual Meeting held in Birmingham Christopher Kong presented early data from a group of five patients receiving what is called photoimmune therapy.
British Society of Gastroenterology Annual Meeting. Birmingham, March 20-23, 2006
A combination of a drug and an photophoresis machine has been used in an attempt to inactivate white cells among patients with Crohn’s disease. The experimental treatment uses the combined action of methoxypsoralen and ultra-violet light to produce a biological effect which could benefit patients whose Crohn’s disease is refractory to other forms of treatment. At the British Society of Gastroenterology Annual Meeting held in Birmingham Christopher Kong presented early data from a group of five patients receiving what is called photoimmune therapy.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.